首页> 外国专利> NOVEL METHODS OF SCREENING SERVING THE PURPOSE OF IDENTIFYING THE FACTORS OF SELECTIVE HEPATITIS C VIRUS REPLICATION INHIBITION

NOVEL METHODS OF SCREENING SERVING THE PURPOSE OF IDENTIFYING THE FACTORS OF SELECTIVE HEPATITIS C VIRUS REPLICATION INHIBITION

机译:筛选选择性肝炎病毒复制抑制因素的目的的新方法

摘要

The present invention relates to novel methods for identifying antiviral agents which selectively interfere with viral proteins that override the interferon(IFN)-induced cellular defense mechanisms against viral infection. In particular, the present invention relates to screening assays that identify agents which selectively inhibit the interaction between viral proteins containing an interferon sensitivity determining region (ISDR) and IFN-induced PKR protein kinase. The present invention more particularly relates to screening assays that identify agents which selectively inhibit the interaction between hepatitis C virus (HCV) nonstructural 5A protein (NS5A), which contains an ISDR, and IFN-induced PKR protein kinase. The interaction between the viral ISDR and IFN-induced PKR protein kinase results in the override of IFN-induced cellular defense mechanisms to combat viral infection. Therefore the agents identified using the assays of the invention may have utility as antiviral agents.
机译:本发明涉及鉴定抗病毒剂的新方法,所述抗病毒剂选择性地干扰覆盖干扰素(IFN)诱导的针对病毒感染的细胞防御机制的病毒蛋白。特别地,本发明涉及筛选测定法,其鉴定出试剂,该试剂选择性地抑制含有干扰素敏感性决定区(ISDR)的病毒蛋白与IFN诱导的PKR蛋白激酶之间的相互作用。本发明更特别地涉及筛选试验,该筛选试验鉴定了选择性抑制包含ISDR的丙型肝炎病毒(HCV)非结构性5A蛋白(NS5A)与IFN诱导的PKR蛋白激酶之间相互作用的试剂。病毒ISDR和IFN诱导的PKR蛋白激酶之间的相互作用导致IFN诱导的抵抗病毒感染的细胞防御机制被超越。因此,使用本发明的测定法鉴定的试剂可用作抗病毒剂。

著录项

  • 公开/公告号PL335721A1

    专利类型

  • 公开/公告日2000-05-08

    原文格式PDF

  • 申请/专利权人 RIBOGENEINC.;

    申请/专利号PL19980335721

  • 发明设计人 KATZE MICHAEL G.;GALE MICHAEL J.JR;

    申请日1998-03-05

  • 分类号C12Q1/70;

  • 国家 PL

  • 入库时间 2022-08-22 01:55:15

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号